| P50 | author | Rebeca Martín | Q57061138 |
| P2093 | author name string | P Langella | |
| | C L Hayes | |
| | E F Verdu | |
| | J Jury | |
| | J M M Natividad | |
| P2860 | cites work | Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment | Q21562212 |
| | Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks | Q27001084 |
| | Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation | Q27327276 |
| | Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment | Q28710518 |
| | Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 |
| | An update on the use and investigation of probiotics in health and disease | Q30407565 |
| | A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases | Q31057363 |
| | Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors | Q33432739 |
| | High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease | Q33789592 |
| | The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease | Q34528027 |
| | Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. | Q34652744 |
| | High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. | Q35718185 |
| | Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells | Q35872091 |
| | Probiotics for the Treatment of Inflammatory Bowel Disease | Q38009716 |
| | Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome | Q39348241 |
| | Probiotic bacteria enhance murine and human intestinal epithelial barrier function | Q40783633 |
| | Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines | Q42464997 |
| | Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection | Q44165176 |
| | Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. | Q44629149 |
| | Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells | Q45304815 |
| | Phylogenetic analysis of dysbiosis in ulcerative colitis during remission | Q45367129 |
| | In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects | Q53850647 |
| | Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice | Q54334422 |
| | Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. | Q54344439 |
| | Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. | Q54391702 |
| | Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis | Q54511436 |
| | Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells | Q57003105 |
| P433 | issue | 1 | |
| P921 | main subject | colitis | Q2453464 |
| | Bifidobacterium breve | Q2902069 |
| P304 | page(s) | 79-88 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Beneficial microbes | Q27722361 |
| P1476 | title | Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration | |
| P478 | volume | 5 | |